EBIT: Income before interest and taxes.
Helix BioPharma Corp. (T.HBP) had EBIT of -3.87M for the most recently reported fiscal year, ending 2025-07-31.
| Income Statement Financials | |
-- |
|
-3.73M |
|
-- |
|
-- |
|
-- |
|
-3.87M |
|
-- |
|
-3.73M |
|
-3.74M |
|
-3.73M |
|
-3.73M |
|
-3.73M |
|
-3.74M |
|
|
EBIT |
-3.87M |
-3.86M |
|
55.74M |
|
55.74M |
|
-0.06 |
|
-0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.47M |
|
-- |
|
-- |
|
-- |
|
2.30M |
|
11.17M |
|
-2.01M |
|
11.17M |
|
74.16M |
|
| Cash Flow Statement Financials | |
-2.74M |
|
0.01M |
|
2.00M |
|
0.77M |
|
0.05M |
|
-0.73M |
|
0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.40% |
|
185.69% |
|
-27.68% |
|
-32.69% |
|
0.21 |
|
-0.05 |
|
-0.05 |
|